KBC Group’s Cantel Medical Corporation CMD Stock Holding History

KBC Group’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-7,173	Closed	-$559K	–	1348
2016 Q3	$559K	Hold	7,173	–	–	0.01%	932
2016 Q2	$493K	Hold	7,173	–	–	0.01%	881
2016 Q1	$512K	Buy	+7,173	New	+$450K	0.01%	833
2015 Q4	–	Sell	-35,103	Closed	-$1.99M	–	1347
2015 Q3	$1.99M	Hold	35,103	–	–	0.04%	437
2015 Q2	$1.88M	Hold	35,103	–	–	0.02%	570
2015 Q1	$1.67M	Sell	35,103 -932	-3%	-$41.3K	0.02%	598
2014 Q4	$1.56M	Buy	+36,035	New	+$1.47M	0.02%	647

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KBC Group's CMD Position: Q4 2016 in Review

KBC Group sold out of Cantel Medical Corporation (CMD) in Q4 2016, closing a stake of 7,173 shares — an estimated $559K sold.

KBC Group first reported a position in CMD in Q4 2014 and held it in 7 quarters. The position peaked at $1.99M in Q3 2015. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

KBC Group reported no remaining Cantel Medical Corporation position as of Q4 2016 after selling out during the quarter.
KBC Group sold 7,173 Cantel Medical Corporation shares in Q4 2016, an estimated $559K.
KBC Group first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 7 quarters.
KBC Group's Cantel Medical Corporation position peaked at $1.99M in Q3 2015.
234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on KBC Group's 13F filing for Q4 2016, filed 16 Feb 2017.